Viewing Study NCT06484660



Ignite Creation Date: 2024-07-17 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06484660
Status: RECRUITING
Last Update Posted: 2024-07-05
First Post: 2024-06-26

Brief Title: Efficacy Of Minimally Invasive Approach In The Surgical Treatment Of Complex Perianal Fistula
Sponsor: Hospital Son Llatzer
Organization: Hospital Son Llatzer

Study Overview

Official Title: Efficacy Of Minimally Invasive Approach In The Mucosal Advancement Flap Technique For The Surgical Treatment Of Previously Untreated Complex Perianal Fistula
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to study whether the minimally invasive approach in the mucosal advancement flap technique for the treatment of complex perianal fistula improves the healing rate compared to non-minimally invasive surgery

The main question it aims to answer is

- Does the healing rate of patients undergoing minimally invasive approach in the mucosal advancement flap technique improve compared to patients undergoing non-minimally invasive surgery

Researchers will also compare minimally invasive approach in the mucosal advancement flap technique to the non-minimally invasive approach in terms of postoperative pain fecal incontinence and healing time

Quality of life and global morbidity will also be analyzed

Participants will

Undergo surgical treatment of complex perianal fistula performed by mucosal advancement flap performed by a minimally invasive technique
Attend control visits and fill in symptom forms one week one month three months and six months after the surgical procedure
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None